Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |